Adult patients with cancer have impaired humoral responses to complete and booster COVID-19 vaccination, especially those with hematologic cancer on active …
E Liatsou, I Ntanasis-Stathopoulos, S Lykos… - Cancers, 2023 - mdpi.com
Simple Summary Taking into consideration the high risk of patients with cancer for severe
COVID-19 infection, prioritization has been given to primary prevention with both primary …
COVID-19 infection, prioritization has been given to primary prevention with both primary …
Prediction of severe infections in chronic lymphocytic leukemia: a simple risk score to stratify patients at diagnosis
R Murru, A Galitzia, L Barabino, R Presicci… - Annals of …, 2024 - Springer
Abstract Chronic Lymphocytic Leukemia (CLL) is well-known for increasing susceptibility to
infections. Factors such as immune dysregulation, IGHV status, hypogammaglobulinemia …
infections. Factors such as immune dysregulation, IGHV status, hypogammaglobulinemia …
Dynamics of humoral and cellular response to three doses of anti-SARS-CoV-2 BNT162b2 vaccine in patients with hematological malignancies and older subjects
V Laquintana, C Mottini, F Marchesi… - Frontiers in …, 2024 - frontiersin.org
Background Few data are available about the durability of the response, the induction of
neutralizing antibodies, and the cellular response upon the third dose of the anti-severe …
neutralizing antibodies, and the cellular response upon the third dose of the anti-severe …
[PDF][PDF] Three is better than two: humoral response in allogeneic HSCT after the third BNT162b2 SARS-CoV-2 mRNA vaccine
L Barabino, A Galitzia, R Murru… - Eur Rev Med …, 2023 - europeanreview.org
6915 previously responded to the second dose had a seroconversion, with a median IgG
SARS-CoV-2 titer of 1,230 (403-2,080) BAU/mL. Only one patient did not experience an …
SARS-CoV-2 titer of 1,230 (403-2,080) BAU/mL. Only one patient did not experience an …